Navigation Links
Regence Teams With U.S. Bank to Offer New Health Savings Account Solution
Date:10/29/2008

PORTLAND, Ore., Oct. 29 /PRNewswire/ -- Members who choose Regence's Health Savings Account (HSA) will soon benefit from a new banking option, now that the company has added U.S. Bank as a banking partner. Regence selected U.S. Bank for its comprehensive approach to health care banking and its strong consumer track record.

"We are proud to partner with an established financial institution and brand like U.S. Bank to offer our members the superior level of quality and financial services they have come to expect from Regence," said Cary Badger, vice president of Market Development for Regence. "U.S. Bank's experience, strong brand recognition and flexibility in online servicing capabilities embody our shared philosophy of supporting members in their health care decisions."

U.S. Bank will serve as the debit card issuer and funds custodian for the Regence HSA. Their responsibilities will include providing account banking and all debit card services, card administration, customer service, web site portal maintenance and issuance of bank and tax statements. Their web site also provides easy access to the member accounts, and employer and agent tools.

"We are very pleased and honored that Regence chose us as their HSA partner," said Ralph Bernstein, U.S. Bank's senior vice president of Healthcare Payment Solutions. "Together, our two companies share a long-standing commitment to outstanding customer support and service. We look forward to working with Regence to demonstrate our commitment to their members, every day."

Each of Regence's partner banks hosts a co-branded web site that enables employers to monitor their HSA program and provides members 24-hour access to their account deposits and balance transaction history. With Regence's new HSA 2.0, scheduled for launch later this year, members will receive a Regence co-branded debit card to pay for any qualified medical expense.

About U.S. Bank

U.S. Bancorp (NYSE: '/>"/>

SOURCE Regence
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Regence Offers InterM to Fill Gap for the Uninsured
2. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
3. Regence Expands MedAdvantage Market, Hits the Road to Educate Seniors
4. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
5. Regence Introduces Two New Plans Designed Especially for Small to Mid-Size Companies
6. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
7. American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company
8. Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need
9. myRegence.com Wins Three Gold Awards from eHealthcare Strategy & Trends
10. Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
11. Regence Automates Provider Contracting with Kryptiqs Choreo Contract Manager
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Breaking Medicine Technology:CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 1DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 2DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 3DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 5DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 6DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 7DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 9DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 10DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 11DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 12DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 1Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 2Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 3Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 4Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 5Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 6Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 7Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 8Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 9Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 10Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 11Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 12Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 14Dr James OConnell Named J H Kanter Prize Laureate 54148 1Dr James OConnell Named J H Kanter Prize Laureate 54148 2Dr James OConnell Named J H Kanter Prize Laureate 54148 3